Osteochondritis Dessicans- Primary Fixation using Bioabsorbable Implants.
Anand Galagali1, Muralidhar Rao1
1Dept of Orthopaedics Manipal Hospital, Bangalore.
This study presents a successful case of treating stage IV Osteochondritis dissecans (OCD) in a young patient using bioabsorbable implants for primary fragment fixation. Early surgical intervention with these implants shows promising clinical and functional outcomes for unstable OCD lesions.
Area of Science:
- Orthopedic Surgery
- Biomaterials Science
Background:
- Osteochondritis dissecans (OCD) involves separation of articular cartilage and subchondral bone.
- Early diagnosis and primary fixation of unstable OCD fragments are crucial for favorable surgical outcomes.
- Bioabsorbable implants represent a recent advancement in surgical fixation for OCD.
Observation:
- A 14-year-old female presented with acute right knee pain, swelling, and inability to bear weight after dance practice.
- MRI revealed a free, stage IV osteochondral fragment measuring 20x8mm.
- The fragment was treated with primary fixation using bioabsorbable implants.
Findings:
- The patient experienced excellent clinical and functional recovery at a 10-month follow-up.
- This case demonstrates the successful application of bioabsorbable implants in managing stage IV OCD.
- Primary fixation of OCD fragments, when feasible, offers significant advantages.
Implications:
- This case highlights the potential of bioabsorbable implants for early, primary fixation of unstable OCD.
- It suggests a novel, effective treatment option for stage IV Osteochondritis dissecans.
- Further research into bioabsorbable implants for OCD treatment is warranted.
More Related Videos
15:11Surgical Fixation of Sternal Fractures: Preoperative Planning and a Safe Surgical Technique Using Locked Titanium Plates and Depth Limited Drilling
Published on: January 5, 2015
11:21Development of a Novel Internal Fixation Model for Rat Radial Fractures: Fracture Healing Assessment and Dorsal Root Ganglion Isolation
Published on: March 13, 2026
